Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
A New Obesity Contender From China Targeting Same Receptors As Eli Lilly's Blockbuster
11:21am, Thursday, 24'th Jul 2025
The Chinese drug company is looking to break into the big league for weight-loss treatments after its injection demonstrated sustained weight loss in Phase Three trials
How Will Eli Lilly's Oncology Drugs Perform in Q2 Earnings?
11:06am, Thursday, 24'th Jul 2025
LLY's oncology sales are expected to have climbed in Q2, led by Verzenio growth, despite pressure from older cancer drugs.
Lilly confirms date and conference call for second-quarter 2025 financial results announcement
10:00am, Thursday, 24'th Jul 2025
INDIANAPOLIS , July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its second-quarter 2025 financial results on August 7, 2025. Lilly will also conduct a conference call that
This Weight-Loss Stock Sank After Earnings. It's Still a Risk for Eli Lilly, Novo Nordisk.
08:48am, Thursday, 24'th Jul 2025
Viking Therapeutics is expected to disclose data on its oral weight-loss drug VK2735.
Gate Bioscience Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Molecular Gate Medicines
08:00am, Thursday, 24'th Jul 2025
BRISBANE, Calif.--(BUSINESS WIRE)--Gate Bioscience, a biotechnology company developing molecular gates, a new class of small molecule drugs to eliminate disease-causing proteins at their source, today
Lilly and Verve announce expiration of Verve tender offer
08:00am, Thursday, 24'th Jul 2025
INDIANAPOLIS , July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (NASDAQ: VERV) today announced that the tender offer to purchase all of the issued and outst
Healthcare Stocks Hit Valuation Bottom, 3 Names to Rebound
04:13pm, Wednesday, 23'rd Jul 2025
The excitement around artificial intelligence (AI) has led to most attention—and capital–being concentrated in one corner while forgetting others, creating a gap and massive opportunity for rotati
Why Eli Lilly (LLY) is a Top Growth Stock for the Long-Term
10:45am, Tuesday, 22'nd Jul 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Better Growth Buy: Eli Lilly vs. Viking Therapeutics
07:15am, Tuesday, 22'nd Jul 2025
Eli Lilly (LLY -1.24%) and Viking Therapeutics (VKTX -0.12%) have garnered considerable attention over the past year due to their solid clinical progress. However, these drugmakers have also lagged th
3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results
04:14am, Tuesday, 22'nd Jul 2025
Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, long-term investors should have a balanced approach to potentially positiv
5 Monster Stocks to Hold for the Next 25 Years
03:32am, Tuesday, 22'nd Jul 2025
The ultimate win for investors is finding a remarkable company that is not only highly productive, but also capable of growth over many years, resulting in substantial returns for long-term shareholde
Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade
06:46pm, Monday, 21'st Jul 2025
Eli Lilly (LLY) closed at $762.18 in the latest trading session, marking a -1.23% move from the prior day.
Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
10:49am, Sunday, 20'th Jul 2025
President Donald Trump's trade policies have caused tumult on Wall Street. The president has pushed for aggressive tariffs on imported goods in an attempt to bring manufacturing jobs back to the count
Calls of the Day: Eli Lilly and Materion
01:25pm, Friday, 18'th Jul 2025
The Investment Committee debate the latest Calls of the Day.
Brokers Suggest Investing in Lilly (LLY): Read This Before Placing a Bet
10:30am, Friday, 18'th Jul 2025
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
